Sub acute toxicity assessment of glipizide engineered polymeric nanoparticles

Journal of Biomedical Nanotechnology

Volumn 7, Issue 4, 2011, Pages 578-589

  Dhana Lekshmi, U M ^a   Kishore, Narra ^a   Neelakanta Reddy, P ^a  

^a CENTRAL LEATHER RESEARCH INSTITUTE   (India)

Author keywords

Diabetic therapy; Glipizide; Haemolysis; Polymeric nanoparticle; Toxicity

Indexed keywords

ACUTE TOXICITY; DIABETIC THERAPY; DRUG ADMINISTRATION; GLIPIZIDE; HAEMATOLOGY; HAEMOLYSIS; HISTOPATHOLOGICAL EXAMINATIONS; IN-VITRO; METHYL METHACRYLATES; NORMAL CONTROLS; ORAL ADMINISTRATION; ORAL ROUTE; PATIENT COMFORT; POLYMERIC NANOPARTICLES; SHELF LIFE; TOXIC EFFECT;

BLOOD; ESTERS; NANOPARTICLES; RATS; TISSUE; TOXICITY;

POLYMERS;

CHITOSAN; ETHYL CELLULOSE; ETHYLCELLULOSE NANOPARTICLE; GLIPIZIDE; NANOPARTICLE; POLY(METHYL METHACRYLATE); POLYMER; SODIUM CHLORIDE; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT; CELLULOSE; DRUG DERIVATIVE; NANOCAPSULE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOENGINEERING; BLOOD CHEMISTRY; CONTROLLED STUDY; CYTOTOXICITY; DRUG FORMULATION; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; DRUG SOLUBILITY; FEMALE; HEMATOLOGY; HISTOPATHOLOGY; IN VITRO STUDY; MATERIAL COATING; NONHUMAN; PARTICLE SIZE; POLYMERIZATION; RAT; TOXICITY TESTING; ANIMAL; CHEMISTRY; DRUG EFFECT; HEMOLYSIS; NANOTECHNOLOGY; ORAL DRUG ADMINISTRATION; SCANNING ELECTRON MICROSCOPY; ULTRASTRUCTURE; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; CELLULOSE; CHITOSAN; FEMALE; GLIPIZIDE; HEMOLYSIS; HYPOGLYCEMIC AGENTS; MICROSCOPY, ELECTRON, SCANNING; NANOCAPSULES; NANOTECHNOLOGY; PARTICLE SIZE; POLYMETHYL METHACRYLATE; RATS; RATS, WISTAR;

EID: 80052914832     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2011.1317     Document Type: Article

References (56)

1. G. Kadhe and R. E. Arasan, Advances in drug delivery of oral hypoglycemic agents. Curr. Sci. 83, 1539 (2002).
2. R. N. Brogden, R. C. Heel, and G. E. Pakes, Glipizide: A review of its pharmacological properties and therapeutic properties. Drugs. 18, 329 (1979).
3. R. Charles and M. D. Shuman, Glipizide an overview. Am. J. Med. 75, 55 (1983).
4. T. S. Holgate, Exposure, uptake, distribution and toxicity of nanomaterials. J. Biomed. Nanotechnol. 6, 1 (2010).
5. C. Vauthier and P. Couvreur, Nanomedicine a new approach for the treatment of serious diseases. J. Biomed. Nanotechnol. 3, 223 (2007).
6. C. W. Lam, J. T. James, R. Mc Cluskey, and R. L. Hunter, Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol. Sci. 77, 126 (2004).
7. A. Dhawan, A. Pandey, and V. Sharma, Toxicity Assessment of Engineered Nanomaterials: Resolving the Challenges. J. Biomed. Nanotechnol. 7, 6 (2011).
8. E. Oberdorster and J. Oberdorster, Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 113, 823 (2005).
9. M. R. Wiesner, G. V. Lowry, P. Alvarez, D. Dionysiou, and P. Biswas, Assessing the risks of manufactured nanomaterials. ES&T. 40, 4336 (2006).
10. E. B. Souto, P. M. Lopes, C. M. Lopes, I. Gaivão, A. M. Silva, and H. G. Pinto, A note on regulatory concerns and toxicity assessment in lipid-based delivery systems (LDS). J. Biomed. Nanotechnol. 5, 317 (2009).
11. Y. L. Zhao, H. Meng, Z. Chen, F. Zhao, and Z. F. Chai, Dependence of nanotoxicity on nanoscale characteristics and strategies for reducing and eliminating nanotoxicity, Nanotoxicology, edited by Y. L. Zhao and H. S. Nalwa, American Scientific Publishers, California (2007), pp. 265-280.
12. J. F. Hillye and R. M. Abrecht, Gastro intestinal per sorption and tissue distribution of differently sized colloidal gold nanoparticles. J. Pharm. Sci. 90, 1927 (2001).
13. G. M. Hodges, E. A. Carr, R. A Hazzard, O. Roilly, and K. E. Carr, A commentary on morphological and quantitative aspects of micro particle translocation across the gastro intestinal mucosa. J. Drug Target. 3, 57 (1995).
14. K. Donaldson, X. Y. Li, and N. W. Mac, Ultrafine (nanometer) particle mediated lung injury. J. Aerosol Sci. 29, 553 (1998).
15. T. G. M. Smijs and J. A. Bouwstra, Focus on skin as a possible port of entry for solid nanoparticles and the toxicological impact. J. Biomed. Nanotechnol. 6, 469 (2010).
16. B. Baroli, Skin absorption and potential toxicity of nanoparticulate nanomaterials. J. Biomed. Nanotechnol. 6, 485 (2010).
17. P. S. Melo, M. M. M. De Azevedo, L. Frungillo, M. C. Anazetti, P. D. Marcato, and N. Durán, Nanocytotoxicity: Violacein and violacein-loaded poly(D,L-lactide-co-glycolide) nanoparticles acting on human leukemic cells. J. Biomed. Nanotechnol. 5, 192 (2009).
18. A. K. Verma, R. P. Pandey, A. Chanchal, and P. Sharma, Immunopotentiating role of encapsulated proteins of infectious diseases in biopolymeric nanoparticles as a potential delivery system. J. Biomed. Nanotechnol. 7, 63 (2011).
19. K. T. Bock and W. B. Muller, A novel assay to determine the haemolytic activity of drugs incorporated in colloidal carrier systems. Pharm. Res. 11, 589 (1994).
20. R. T. Mehta, R. L. Hopfer, R. L. Juliano, and G. Lopoz-Berestein, A comparison of in-vitro toxicity and antifungal efficacy of membrane active drugs after liposome encapsulation. Select Cancer Ther. 5, 113 (1989).
21. D. Forster, C. Washington, and S. S. Davis, Toxicity of solubilised and colloidal amphotericin B formulation to human erythrocytes. J. Pharm. Pharmacol. 40, 325 (1988).
22. J. C. Seagrave, J. D. Mc Donald, A. P. Giglotti, K. J. Nikula, S. K. Seikop, M. Gurevich, and J. L. Mauderly, Mutagenicity and in vivo toxicity of combined particulate and semi volatile organic fractions of gasoline and diesel engine emissions. Toxicol. Sci. 70, 212 (2002).
23. J. C. Seagrave, J. D. Mc Donald, A. P. Giglotti, K. J. Nikula, S. K. Seikop, M. Gurevich, and J. L. Mauderly, In vitro versus in vivo exposure to combustion emissions. Exp. Toxicol. Pathol. 57, 233 (2005).
24. M. C. Sayes, L. K. Reed, and B. D. Warheit, Assessing toxicity of fine and nanoparticles: Comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol. Sci. 97, 163 (2007).
25. P. Sharma and J. D. Sharma, In vitro haemolysis of human erythrocytes by plant extracts with antiplasmodic activity. J . Ethnopharmacol. 74, 239 (2001).
26. A. M. Fan and G. Alexeeff, Nanotechnology and nanomaterials: Toxicology, risk assessment, and regulations. J. Nanosci. Nanotechnol. 10, 8646 (2010).
27. B. Patrick, O. Donnell, W. James, and Mc Ginity, Preparation of microspheres by the solvent evaporation technique. Adv. Drug. Deliver. Rev. 28, 25 (1997).
28. T. Govender, S. Stolnik, C. G. Martin, L. Illum, and S. D. Stanley, PLGA nanoparticles prepared by nanoprecipitation: Drug loading and release studies of a water soluble drug. J. Control. Rel. 57, 171 (1999).
29. J. W. Mc Ginity and P. B. O'Donnell, Preparation of microspheres by the solvent evaporation technique. Adv. Drug. Deliver. Rev. 28, 25 (1997).
30. U. M. Dhana lekshmi, G. Poovi, Narra Kishore, and P. Neelakanta Reddy, In vitro characterization and in vivo toxicity study of repaglinide loaded poly(methyl methacrylate) nanoparticles. Int. J. Pharm. 396, 194 (2010).
31. Duane T. Birnbaum, Jacequeline D. kosmala, and Lisa Brannon peppas, Optimization of preparation techniques for poly(lactic acid-co-glycolic acid) nanoparticles. J. Nanoparticle Research. 2, 173 (2000).
32. V. Bulmus, M. Woodward, L. Lin, N. Murthy, P. Stayton, and A. Hoffmann, A new pH responsive glutathione-reactive, endosomal membrane-disruptive polymeric carrier for intracellular delivery of biomolecular drugs. J. Control. Rel. 93, 105 (2003).
33. S. E. Gelperina, A. Khalansky, Z. S. Smirnova, A. I. Bobruskin, and S. E. Severin, Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma. Toxicol. lett. 126, 131 (2002).
34. I. S. Rodriguez, P. Campillo, A. Alexander, M. Teresa, G. Lercker, and H. Garcia, Bio chemical and histopathological effects of dietary oxidized cholesterol in rats, J . Appl. Toxicol 29, 715 (2009).
35. M. Gregory, C. J. Sheeba, V. K. Kalaichelvan, R. Manavalan. P. Neelakanta Reddy, and G. Franklin, Poly DL lactide co glycolic acid nanoencapsulation reduces erlotinib induces sub acute toxicity in rat. J. Biomed. Nanotechnol. 5, 1 (2009).
36. M. Wang, J. Yao, J. Y. Chen, W. X. Bai, Y. M. Sheng, W. N. Pan, Y. Y. Pan, and F. L. Yu, A sub chronic Intravenous toxicity study of magnesium fructose 16 diphosphater in beagle dogs. Basic Clin. Pharmacol. Toxicol. 104, 93 (2008).
37. M. Hua Han, J. Clen, J. Wing, and X. T. Wang, Blood compatibility of poly aminodiamine dendrimers and erythrocyte protections. J. Biomed. Nanotechnol. 6, 82 (2010).
38. K. J. Sunil, A. M. Awasthi, N. K. Jain, and G. P. Agarwal, Calcium silicate based microspheres of repaglinide for gastro retentive floating drug delivery: Preparation and in vitro characterization. J. Control. Rel. 107, 300 (2005).
39. I. Bala, S. Hariharan, and M. N. Kumar, PLGA nanoparticles in drug delivery the state of art. Crit. Rev. Ther. Drug Carr. Sys. 21, 387 (2004).
40. N. Malik, R. Wiwattana Patapee, R. Klopsch, K. Lorenz, H. Frey, J. W. Weener, and R. Duccan, Dendrimers: Relation between structure and biocompatibility. J. Control. Rel. 65,133 (2000).
41. K. K. Chakraborthy, Therapeutic and haemolytic evaluation of insitu liposomal preparation containing amphotericin β cyclodextrins. J. Pharm. Pharm. Sci. 6, 231 (2003).
42. M. Hu, K. Konoki, and K. Tachibana, Cholesterol independent membrane disruption caused by triterpenoid saponins. Biochim Biophys Acta. 1299, 252 (1996).
43. D. W. Lee, K. Powersh, and R. Baney, Physiochemical properties and blood compatibility of a cyclated chitosan nanaoparticles. Carbohyd. Polym. 58, 371 (2004).
44. L. Gonzalez, S. Corradi, L. C. J. Thomassen, J. A. Martens, E. Cundari, D. Lison, and M. Kirsch-Volders, Methodological approaches influencing cellular uptake and cyto-(geno) toxic effects of nanoparticles. J. Biomed. Nanotechnol. 7, 3 (2011).
45. C. Chen, Y. C. Cheng, C. H. Yu, S. W. Chen, M. K. Cheung, and P. H. Yu, In vitro cytotoxicity, haemolysis assay and bio degradation behavior of biodegradable poly(3 hydroxy butyrate)-poly(ethylene glycol-poly(3-hydroxyl butyrate nanoparticles as potential drug carriers, J . Biomed. Mater. Res. A. 290 (2008).
46. M. Raza, O. A. Al-Shabanah, T. M. El-Hadiyah, and A. A. Al- Majed, Effect of prolonged vigabatrin treatment on hematological and biochemical parameters in plasma, liver and kidney of Swiss albino mice. Sci. Pharm. 70, 135 (2002).
47. S. Teo, D. Stirling, S. Thomas, A. Hoberman, A. Kiorpes, and V. Khetani, A 90 day oral gavage toxicity study of d-methylphenidate in Sprague-Dawley rats. Toxicol. 179, 183 (2002).
48. J. H. Ji, J. H. Jung, S. S. Kim, J. U. Yoon, J. D. Park, B. S. Choi, Y. H. Chung, and I. J. Yu, A twenty eight day inhalation toxicity study of silver nanoparticles in Sprague dawley rats. Inhal. Toxicol. 198, 57 (2007).
49. F. L. A. Willekens, B. R. K. Stoelwinder, Y. A. M. G. Dopp, H. J. Bos, and J. M. Were, Haemoglobin loss from erythrocytes in vivo result from spleen facilitated vesiculation. Blood 101, 744 (2003).
50. L. A. Kotkoskie and C. Freeman, Subchronic oral toxicity study of aquacoat ECD Ethylcellulose aqueous dispersion in the rat. Food Chemi. Toxicol. 36, 705 (1998).
51. S. L. Barry, Animal Clinical Pathology, edited by J. D. Micheal and A. H. Manfred, CRC Handbook of Toxicology, CRC Press, USA (1995).
52. B. V. Feldmann, J. G. Zinkl, and N. C. Jain, Schalms Veterinary Haematology, Lea Febiger, Philadelphia (2002).
53. B. Pilo, M. V. Asnani, and R. V. Shah, Studies on wound healing and repair in pigeon liver II: Histochemical studies during acid and alkaline phosphatese during the process. J. Animal. Morphol. Physiol. 19, 205 (1972).
54. M. Kumar Chaubey and R. Kant Upadhyay, Bio chemical and enzymatic changes after black scorpion Heterometrus fastigious Couzijn envenomation in experimental albino mice. J. Appl. Toxicol. 28, 874 (2008).
55. B. Ali and A. Basher, Toxicological studies on three leaves of avicennia marina in rats. J. Appl. Toxicol. 18, 111 (1998).
56. Y. S. Kim, J. Sikkim, H. S. Cho, D. S. Rha, and I. Yu, Twenty eight days oral toxicity, Genotoxicity and gender related tissue distribution of silver nanoparticles in Sprague Dawley rats. Inhal. Toxicol. 20, 575 (2008).